世界のインフルエンザウイルスベクターワクチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Influenza Virus Vector Vaccine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3168 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：New Technology

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、インフルエンザウイルスベクターワクチンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・インフルエンザウイルスベクターワクチンの市場動向 ・企業の競争状況、市場シェア ・インフルエンザウイルスベクターワクチンの種類別市場規模（開発中、前臨床、臨床I、臨床II） ・インフルエンザウイルスベクターワクチンの用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他） ・インフルエンザウイルスベクターワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・インフルエンザウイルスベクターワクチンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・インフルエンザウイルスベクターワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・インフルエンザウイルスベクターワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・インフルエンザウイルスベクターワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GREFFEX、CanSino Biologics、Academy of Military Medical Sciences、XMU、HKU、Hualan Biological Engineering、BravoBio） ・結論

The virus-sensitive vector vaccine, which is characterized by nasal drip vaccination, is currently undergoing safety and efficacy studies in experimental animals.

In 2021, the global Influenza Virus Vector Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Influenza Virus Vector Vaccine status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Influenza Virus Vector Vaccine development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Influenza Virus Vector Vaccine Scope and Market Size
Influenza Virus Vector Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Virus Vector Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Being Developed
Preclinical
Clinical I
Clinical II

Segment by Application
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
GREFFEX
CanSino Biologics
Academy of Military Medical Sciences
XMU
HKU
Hualan Biological Engineering

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Virus Vector Vaccine Market Size Growth Rate by Type (2021-2027)
1.2.2 Being Developed
1.2.3 Preclinical
1.2.4 Clinical I
1.2.5 Clinical II
1.3 Market by Application
1.3.1 Global Influenza Virus Vector Vaccine Market Share by Application (2021-2027)
1.3.2 Pharmaceutical And Biotechnology Companies
1.3.3 Hospital
1.3.4 Academic And Research Organizations
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Influenza Virus Vector Vaccine Market Size
2.2 Influenza Virus Vector Vaccine Market Size by Regions
2.2.1 Influenza Virus Vector Vaccine Growth Rate by Regions (2021-2027)
2.2.2 Influenza Virus Vector Vaccine Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Influenza Virus Vector Vaccine Revenue by Players (2020-2021)
3.2 Influenza Virus Vector Vaccine Key Players Headquaters and Area Served
3.3 Key Players Influenza Virus Vector Vaccine Product/Solution/Service
3.4 Date of Enter into Influenza Virus Vector Vaccine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown by Type and by Application
4.1 Global Influenza Virus Vector Vaccine Market Size by Type (2021-2027)
4.2 Global Influenza Virus Vector Vaccine Market Size by Application (2021-2027)

5 North America
5.1 North America Influenza Virus Vector Vaccine Market Forecast (2021-2027)
5.2 Influenza Virus Vector Vaccine Key Players in North America
5.3 North America Influenza Virus Vector Vaccine Market Size by Type
5.4 North America Influenza Virus Vector Vaccine Market Size by Application

6 Europe
6.1 Europe Influenza Virus Vector Vaccine Market Forecast (2021-2027)
6.2 Influenza Virus Vector Vaccine Key Players in Europe
6.3 Europe Influenza Virus Vector Vaccine Market Size by Type
6.4 Europe Influenza Virus Vector Vaccine Market Size by Application

7 Japan
7.1 Japan Influenza Virus Vector Vaccine Market Forecast (2021-2027)
7.2 Influenza Virus Vector Vaccine Key Players in Europe
7.3 Japan Influenza Virus Vector Vaccine Market Size by Type
7.4 Japan Influenza Virus Vector Vaccine Market Size by Application

8 Rest of World
8.1 China
8.1.1 China Influenza Virus Vector Vaccine Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Influenza Virus Vector Vaccine Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Influenza Virus Vector Vaccine Market Analysis
8.3.2 Key Players in India

9 International Player Profiles
9.1 GREFFEX
9.1.1 GREFFEX Company Details
9.1.2 GREFFEX Description and Business Overview
9.1.3 GREFFEX Influenza Virus Vector Vaccine Introduction
9.1.4 GREFFEX Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.1.5 GREFFEX Recent Development
9.2 CanSino Biologics
9.2.1 CanSino Biologics Company Details
9.2.2 CanSino Biologics Description and Business Overview
9.2.3 CanSino Biologics Influenza Virus Vector Vaccine Introduction
9.2.4 CanSino Biologics Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.2.5 CanSino Biologics Recent Development
9.3 Academy of Military Medical Sciences
9.3.1 Academy of Military Medical Sciences Company Details
9.3.2 Academy of Military Medical Sciences Description and Business Overview
9.3.3 Academy of Military Medical Sciences Influenza Virus Vector Vaccine Introduction
9.3.4 Academy of Military Medical Sciences Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.3.5 Academy of Military Medical Sciences Recent Development
9.4 XMU
9.4.1 XMU Company Details
9.4.2 XMU Description and Business Overview
9.4.3 XMU Influenza Virus Vector Vaccine Introduction
9.4.4 XMU Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.4.5 XMU Recent Development
9.5 HKU
9.5.1 HKU Company Details
9.5.2 HKU Description and Business Overview
9.5.3 HKU Influenza Virus Vector Vaccine Introduction
9.5.4 HKU Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.5.5 HKU Recent Development
9.6 Hualan Biological Engineering
9.6.1 Hualan Biological Engineering Company Details
9.6.2 Hualan Biological Engineering Description and Business Overview
9.6.3 Hualan Biological Engineering Influenza Virus Vector Vaccine Introduction
9.6.4 Hualan Biological Engineering Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.6.5 Hualan Biological Engineering Recent Development
9.7 BravoBio
9.7.1 BravoBio Company Details
9.7.2 BravoBio Description and Business Overview
9.7.3 BravoBio Influenza Virus Vector Vaccine Introduction
9.7.4 BravoBio Revenue in Influenza Virus Vector Vaccine Business (2020-2021)
9.7.5 BravoBio Recent Development

10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints

11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Tables
Table 1. Global Influenza Virus Vector Vaccine Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Being Developed
Table 3. Key Players of Preclinical
Table 4. Key Players of Clinical I
Table 5. Key Players of Clinical II
Table 6. Global Influenza Virus Vector Vaccine Market Size Growth by Application (2021-2027) (US$ Million)
Table 7. Global Influenza Virus Vector Vaccine Market Size by Regions (2021-2027) (US$ Million)
Table 8. Global Influenza Virus Vector Vaccine Market Share by Regions (2021-2027)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global Influenza Virus Vector Vaccine Revenue by Players (2020-2021) (US$ Million)
Table 12. Global Influenza Virus Vector Vaccine Market Share by Players (2020-2021)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Influenza Virus Vector Vaccine Product Solution and Service
Table 15. Date of Enter into Influenza Virus Vector Vaccine Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Influenza Virus Vector Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 18. Global Influenza Virus Vector Vaccine Market Size Share by Type (2021-2027)
Table 19. Global Influenza Virus Vector Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 20. Global Influenza Virus Vector Vaccine Market Size Share by Application (2021-2027)
Table 21. North America Key Players Influenza Virus Vector Vaccine Revenue (2020-2021) (US$ Million)
Table 22. North America Key Players Influenza Virus Vector Vaccine Market Share (2020-2021)
Table 23. North America Influenza Virus Vector Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 24. North America Influenza Virus Vector Vaccine Market Share by Type (2021-2027)
Table 25. North America Influenza Virus Vector Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 26. North America Influenza Virus Vector Vaccine Market Share by Application (2021-2027)
Table 27. Europe Key Players Influenza Virus Vector Vaccine Revenue (2020-2021) (US$ Million)
Table 28. Europe Key Players Influenza Virus Vector Vaccine Market Share (2020-2021)
Table 29. Europe Influenza Virus Vector Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 30. Europe Influenza Virus Vector Vaccine Market Share by Type (2021-2027)
Table 31. Europe Influenza Virus Vector Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 32. Europe Influenza Virus Vector Vaccine Market Share by Application (2021-2027)
Table 33. Japan Key Players Influenza Virus Vector Vaccine Revenue (2020-2021) (US$ Million)
Table 34. Japan Key Players Influenza Virus Vector Vaccine Market Share (2020-2021)
Table 35. Japan Influenza Virus Vector Vaccine Market Size by Type (2021-2027) (US$ Million)
Table 36. Japan Influenza Virus Vector Vaccine Market Share by Type (2021-2027)
Table 37. Japan Influenza Virus Vector Vaccine Market Size by Application (2021-2027) (US$ Million)
Table 38. Japan Influenza Virus Vector Vaccine Market Share by Application (2021-2027)
Table 39. Key Players in China
Table 40. Key Players in Southeast Asia
Table 41. Key Players in India
Table 42. GREFFEX Company Details
Table 43. GREFFEX Description and Business Overview
Table 44. GREFFEX Influenza Virus Vector Vaccine Product
Table 45. GREFFEX Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 46. GREFFEX Recent Development
Table 47. CanSino Biologics Company Details
Table 48. CanSino Biologics Description and Business Overview
Table 49. CanSino Biologics Influenza Virus Vector Vaccine Product
Table 50. CanSino Biologics Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 51. CanSino Biologics Recent Development
Table 52. Academy of Military Medical Sciences Company Details
Table 53. Academy of Military Medical Sciences Description and Business Overview
Table 54. Academy of Military Medical Sciences Influenza Virus Vector Vaccine Product
Table 55. Academy of Military Medical Sciences Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 56. Academy of Military Medical Sciences Recent Development
Table 57. XMU Company Details
Table 58. XMU Description and Business Overview
Table 59. XMU Influenza Virus Vector Vaccine Product
Table 60. XMU Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 61. XMU Recent Development
Table 62. HKU Company Details
Table 63. HKU Description and Business Overview
Table 64. HKU Influenza Virus Vector Vaccine Product
Table 65. HKU Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 66. HKU Recent Development
Table 67. Hualan Biological Engineering Company Details
Table 68. Hualan Biological Engineering Description and Business Overview
Table 69. Hualan Biological Engineering Influenza Virus Vector Vaccine Product
Table 70. Hualan Biological Engineering Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 71. Hualan Biological Engineering Recent Development
Table 72. BravoBio Company Details
Table 73. BravoBio Description and Business Overview
Table 74. BravoBio Influenza Virus Vector Vaccine Product
Table 75. BravoBio Revenue in Influenza Virus Vector Vaccine Business 2020 and 2021
Table 76. BravoBio Recent Development
Table 77. Influenza Virus Vector Vaccine Market Trends
Table 78. Influenza Virus Vector Vaccine Market Drivers
Table 79. Influenza Virus Vector Vaccine Market Challenges
Table 80. Influenza Virus Vector Vaccine Market Restraints
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Virus Vector Vaccine Market Share by Type in 2021 & 2027
Figure 2. Being Developed Features
Figure 3. Preclinical Features
Figure 4. Clinical I Features
Figure 5. Clinical II Features
Figure 6. Global Influenza Virus Vector Vaccine Market Share by Application in 2021 & 2027
Figure 7. Pharmaceutical And Biotechnology Companies Case Studies
Figure 8. Hospital Case Studies
Figure 9. Academic And Research Organizations Case Studies
Figure 10. Other Case Studies
Figure 11. Influenza Virus Vector Vaccine Report Years Considered
Figure 12. Global Influenza Virus Vector Vaccine Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 13. Global Influenza Virus Vector Vaccine Market Share by Regions (2020-2027)
Figure 14. Global Influenza Virus Vector Vaccine Market Share by Players in 2021
Figure 15. Global Influenza Virus Vector Vaccine Market Size Market Share by Type (2021-2027)
Figure 16. Global Influenza Virus Vector Vaccine Market Size Market Share by Application (2021-2027)
Figure 17. Global Influenza Virus Vector Vaccine Revenue Market Share by Application in 2021
Figure 18. North America Influenza Virus Vector Vaccine Market Size 2021-2027 (US$ Million)
Figure 19. Europe Influenza Virus Vector Vaccine Market Size 2021-2027 (US$ Million)
Figure 20. Japan Influenza Virus Vector Vaccine Market Size 2021-2027 (US$ Million)
Figure 21. Influenza Virus Vector Vaccine Market Size in China (2021-2027) (US$ Million)
Figure 22. Influenza Virus Vector Vaccine Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 23. Influenza Virus Vector Vaccine Market Size in India (2021-2027) (US$ Million)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

---